PharmaResearch Co., Ltd. (214450) Stock Forecast & Price Target
214450 Analyst Ratings
There are no analyst ratings in the last 3 months.
214450 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
No analyst ratings match these filters.
Stocks with the Highest Top Analyst Consensus in the General Sector
214450 Financial Forecast
HighKRW 3.36K
ConsensusKRW 3.36K
LowKRW 3.36K
214450 Earnings Forecast
Next quarter’s earnings estimate for 214450 is KRW 3,355.05 with a range of KRW 3,355.05 to KRW 3,355.05. The previous quarter’s EPS was KRW 4,439.65. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
HighKRW 186B
ConsensusKRW 176B
LowKRW 171B
214450 Sales Forecast
Next quarter’s sales forecast for 214450 is KRW 175.74B with a range of KRW 171.40B to KRW 185.60B. The previous quarter’s sales results were KRW 178.70B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
214450 Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about PharmaResearch Co., Ltd.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of PharmaResearch Co., Ltd.?
To buy shares of KR:214450, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
